Pestonjamasp K N, Mehta N G
Biological Chemistry Division, Tata Memorial Centre, Parel, Bombay, India.
Biochim Biophys Acta. 1991 Mar 4;1073(2):341-6. doi: 10.1016/0304-4165(91)90141-3.
Cellular deformability has been proposed in the past as a major determinant of lectin-mediated agglutination of cells. In this paper we have evaluated the correlation between deformability and Con A-agglutinability of human erythrocytes by subjecting them to agents that alter either one of the properties and evaluating the effect on the other property. The following results have been obtained: (i) Treatment with pronase or trypsin, which makes the Con A-nonagglutinable normal red cells highly agglutinable, has practically no effect on deformability; while neuraminidase treatment, with a similar effect on agglutinability, produces a small but statistically significant reduction in deformability. (ii) Diamide treatment, on the other hand, produces a drastic reduction in the deformability of pronase-treated erythrocytes but has no effect on the Con A-agglutinability of the cells. Dinitrophenol also reduces deformability but without altering the agglutinability, (iii) Chlorpromazine, at 2 x 10(-5) M, does not have any effect on the deformability of trypsinized cells, but increases the agglutinability substantially. When the Con A-agglutinability of the cells and their deformability after these treatments are compared, a correlation coefficient r = -0.353 (P greater than 0.1) is obtained. This indicates the lack of any direct correlation between the two parameters, and rules out any significant role of deformability in the determination of Con A-agglutinability of erythrocytes. The agglutination with the lectin is completely reversed by methyl alpha-D-mannoside, the specific inhibitory sugar for Con A, also ruling out any secondary role for deformability in the non-lectin-mediated stabilization of clumps. Upon incubation of normal erythrocytes with Con A. a dose-dependent decrease in deformability is observed, with the deformability index falling to almost 25% of the normal value with 500 microgram/ml Con A. This indicates that Con A binding to its receptor produces changes in the membrane probably by altering properties of the membrane skeleton.
过去曾有人提出细胞变形性是凝集素介导的细胞凝集的主要决定因素。在本文中,我们通过使人类红细胞受到改变其中一种特性的试剂作用,并评估对另一种特性的影响,来评估红细胞变形性与刀豆球蛋白A(Con A)凝集性之间的相关性。得到了以下结果:(i)用链霉蛋白酶或胰蛋白酶处理,可使原本不能被Con A凝集的正常红细胞变得极易凝集,但对变形性几乎没有影响;而神经氨酸酶处理对凝集性有类似影响,却会使变形性出现微小但具有统计学意义的降低。(ii)另一方面,二酰胺处理会使经链霉蛋白酶处理的红细胞的变形性急剧降低,但对细胞的Con A凝集性没有影响。二硝基苯酚也会降低变形性,但不改变凝集性。(iii)2×10⁻⁵ M的氯丙嗪对经胰蛋白酶处理的细胞的变形性没有任何影响,但会显著增加凝集性。当比较这些处理后细胞的Con A凝集性及其变形性时,得到的相关系数r = -0.353(P大于0.1)。这表明这两个参数之间不存在任何直接相关性,并排除了变形性在决定红细胞Con A凝集性方面的任何重要作用。Con A与红细胞的凝集可被α-D-甲基甘露糖苷完全逆转,α-D-甲基甘露糖苷是Con A的特异性抑制糖,这也排除了变形性在非凝集素介导的凝集块稳定中的任何次要作用。正常红细胞与Con A孵育后,会观察到变形性呈剂量依赖性降低,当Con A浓度为500微克/毫升时,变形性指数降至正常值的近25%。这表明Con A与其受体结合可能通过改变膜骨架的特性而使膜发生变化。